Report
David Wang
EUR 147.86 For Business Accounts Only

Strong Third Quarter for Chemours; Increasing Fair Value to $6, but Shares Remain Overvalued

We are increasing our fair value estimate for Chemours to $6 per share from $4 previously, as we have increased our cash flow expectations for the company following stronger-than-expected third-quarter earnings. Driven by sizable cost cuts and TiO2 price increases, Chemours reported adjusted EBITDA of $268 million, 59% year on year. We have increased our cash flow forecasts for the company based on better-than-expected performance. The company’s high financial leverage, over 40% of the enterpris...
Underlying
Chemours Co.

Chemours is a provider of performance chemicals. The company has three reportable segments: Fluoroproducts, Chemical Solutions, and Titanium Technologies. The company's Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The company's Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, industrial, and consumer applications. The company's Titanium Technologies segment is a provider of titanium dioxide pigment, a white pigment used to deliver whiteness, brightness, opacity, and protection in a variety of applications.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
David Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch